Metformin administration-associated downregulation of platelet-derived growth factor B (PDGF-B) and subsequent inhibition of angiogenesis and the formation of immature vasculature was reported in an in vivo model of breast cancer, leading to metastatic inhibition and sensitization of the breast cancer to chemotherapeutic intervention [107]. This evidence concerns the gene PDGFB and breast carcinoma.